Protenus, a Baltimore, MD-based healthcare compliance analytics company, raised $17M in Series C funding.
The round was led by LTP, with Kaiser Permanente Ventures, F-Prime Capital, Arthur Ventures, Lionbird, and Providence Ventures participating. With this funding round, LTP Co-founder and Managing Partner Jared Kesselheim, M.D., joins the board of directors at Protenus. Dr. Kesselheim is a healthcare industry veteran with 14 years of experience in healthcare as an investor and physician.
The company intends to use the funds to accelerate sales.
Founded in 2014 by Nick Culbertson & Robert Lord, Protenus provides health systems with a healthcare compliance analytics platform to proactively identify risk across the organization, such as inappropriate access to patient data and the theft and misuse of controlled substances by hospital staff.
The healthcare compliance analytics platform uses artificial intelligence to audit every access to patient records for the nation’s leading health systems. Providing healthcare leaders full insight into how health data is being used, and alerting privacy, security and compliance teams to inappropriate activity, the solution allows partner hospitals to make decisions about how to protect their data, their patients, and their institutions.